USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: IASIS MOLECULAR SCIENCES, LLC
City: SPOKANE
State: WA
Zip+4: 99223-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,073,703.00 5

Award List:

A Novel and Tailorable Topical Wound Therapy Based on a Semi-Interpenetrating Polym

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: David J. Vachon
Award Amount: $141,323.00
Abstract:
DESCRIPTION (provided by applicant): Abstract A water-soluble, inexpensive, and biocompatible polymer with unique properties and processing characteristics has been proven effective against multiple serine and metalloproteases in testing. The polymer is us ed to formulate wound therapies that offer… More

A Novel and Tailorable Drug Delivery Device for the Treatment of Periodontitis

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: David J. Vachon
Award Amount: $158,496.00
Abstract:
DESCRIPTION (provided by applicant): This application is directed toward the development of a therapeutic drug conjugates with the intention of providing a cost effective adjunct to scaling and root planing procedures for the reduction of pocket depth in p atients with adult periodontitis. This… More

Topical Modulation of Burn Wound Healing

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: David J. Vachon
Award Amount: $197,677.00
Abstract:
DESCRIPTION (provided by applicant): Our central hypothesis is that the inflammatory response to thermal injury results in an imbalance of endogenous proteases and their inhibitors resulting in impaired healing. In this collaborative effort, we propose tha t burn wound healing can be improved… More

A Novel Electrospun Vascular Graft

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: David J. Vachon
Award Amount: $277,838.00
Abstract:
DESCRIPTION (provided by applicant): A novel sulfonated polymer with unique chemically tailorable properties and processing characteristics has shown considerable promise as a thrombo- resistant surface and has been proven to be an effective inhibitor agai nst neutrophil-derived proteases. Phase 1… More

Treatment of Wound Infection with Novel Uncharged Silver Carbene Complexes

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: David J. Vachon – 509-210-0736
Award Amount: $298,369.00
Abstract:
DESCRIPTION (provided by applicant): Three novel uncharged silver carbene microbicides that have been shown to be effective against a wide variety of pathogens will be formulated into two different ointment formulations and tested in an infected healing model in the diabetic rat. Formulation of the… More